Siponimod and Cognition in Secondary Progressive Multiple Sclerosis: EXPAND Secondary Analyses.
Ralph H B BenedictDavorka TomicBruce A CreeRobert FoxGavin GiovannoniAmit Bar-OrRalf GoldPatrick VermerschHarald PohlmannIan WrightGöril KarlssonFrank DahlkeChristian WolfLudwig KapposPublished in: Neurology (2020)
This study provides Class II evidence that, for patients with SPMS, siponimod had a significant benefit on cognitive processing speed.
Keyphrases